Antibody Targeted Metal–Organic Frameworks for Bioimaging Applications
Source abstract
Abstract
We report on the availability and chemical utility of primary amines within metal-organic frameworks (MOFs) for cell targeting. Primary amine groups represent one of the most versatile chemical moieties for conjugation to biologically relevant molecules, including antibodies and enzymes. Specifically, we used two different chemical conjugations schemes, utilizing the amino functionality on the organic linker: first, carbodiimide chemistry was used to link the primary amine to available carboxyl groups on the protein neutravidin; second, sulfhydryl cross-linking chemistry was used via Traut's reagent scheme. Importantly, this is the first report that documents this methodology implemented with MOF systems. Finally, the ability of the EpCAM antibody targeted MOFs to bind to a human epithelial cell line (A549), a common target for imaging studies, was confirmed with confocal microscopy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Dendrimers and Hyperbranched Polymers · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Molecular and Microbiology Department, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
Nanoscale Sciences Department, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
Funding
Sandia National Laboratories
References (31)
Show source-provided references
1. 10.1021/ar200028a10.1021/ar200028a ↗
2. 10.1002/adma.20170763410.1002/adma.201707634 ↗
3. 10.1016/j.ccr.2017.08.01510.1016/j.ccr.2017.08.015 ↗
4. 10.1098/rsfs.2016.002710.1098/rsfs.2016.0027 ↗
5. 10.1371/journal.pone.018756310.1371/journal.pone.0187563 ↗
6. 10.1021/acsami.6b1157910.1021/acsami.6b11579 ↗
7. 10.1073/pnas.130591011010.1073/pnas.1305910110 ↗
8. 10.1021/ja906198y10.1021/ja906198y ↗
9. 10.1002/anie.20100827710.1002/anie.201008277 ↗
10. 10.1021/ja805884310.1021/ja8058843 ↗
11. 10.1039/C7DT02356A10.1039/C7DT02356A ↗
12. 10.1021/ja062744410.1021/ja0627444 ↗
13. Wang G. D. · Tomography · 2016 · 2 · 17910.18383/j.tom.2016.00226 ↗
14. 10.1039/C8CE00909K10.1039/C8CE00909K ↗
15. 10.1021/acsami.7b0585910.1021/acsami.7b05859 ↗
16. 10.1002/adma.20180020210.1002/adma.201800202 ↗
17. 10.1039/C8CS00014J10.1039/C8CS00014J ↗
18. 10.1016/j.xphs.2019.08.00910.1016/j.xphs.2019.08.009 ↗
19. Hermanson, G. T. In Bioconjugate Techniques, 3rd ed. Hermanson, G. T., Ed. 2013; Chapter 2, pp 127–228.10.1016/B978-0-12-382239-0.00002-9 ↗
20. 10.1021/acsami.8b2169810.1021/acsami.8b21698 ↗
21. 10.1021/cm900166h10.1021/cm900166h ↗
22. 10.2174/1573403X1066614091416055410.2174/1573403X10666140914160554 ↗
23. Park S. · Nat. Rev. Mater. · 2017 · 2 · 1710410.1038/natrevmats.2017.14 ↗
24. 10.1021/jm500410710.1021/jm5004107 ↗
25. 10.1039/C3TB20832J10.1039/C3TB20832J ↗
26. 10.1021/acs.analchem.5b0000110.1021/acs.analchem.5b00001 ↗
27. 10.1021/acs.chemmater.7b0326910.1021/acs.chemmater.7b03269 ↗
28. 10.1002/cplu.20120018610.1002/cplu.201200186 ↗
29. 10.1021/acs.langmuir.7b0206510.1021/acs.langmuir.7b02065 ↗
30. 10.1021/acsnano.6b0281910.1021/acsnano.6b02819 ↗
31. 10.1021/acs.chemmater.7b0312810.1021/acs.chemmater.7b03128 ↗